Areterna

Areterna, LLC. is a wholly-owned subsidiary of Synthgene Biotechnology Co., Ltd., serving customers in the United States and Europe. Synthgene provides materials and services that support mRNA and oligonucleotide production. Founded in 2018 by a group of passionate nucleic acid chemists, the company's mission is to break the bottleneck of raw material supply and develop innovative solutions to support industry clients. With a robust quality system and ISO9001 certification, the company supports cGMP production of mRNA raw materials, including NTP, modified NTP, and cap analogs. For GMP raw materials, a Drug Master File has been submitted to the FDA. Additionally, Synthgene offers analytical development services for mRNA research, mRNA-related impurity standards and test kits, LNP screening services, IVT process development, and IVT kits. In solid-phase DNA and RNA synthesis, Synthgene provides high-quality phosphoramidites to support cGMP oligomer production. With over 200 R&D scientists and an AI-assisted discovery platform, Synthgene continues to introduce new products to the market.